Vaccine Market Analysis and Global Forecast 2023-2033
Price range: $ 1,390.00 through $ 5,520.00
Vaccine Market Research Report: Information By Type (Monovalent Vaccines, Multivalent Vaccines), By Indication (Pneumococcal Diseases, DTP, HPV, Influenza, Meningococcal Disease, Polio, Hepatitis, Rotavirus, MMR, Varicella, Herpes Zoster, Ebola, COVID, Others), By Application (Conjugate Vaccines, Inactivated & Subunit, Live Attenuated, Recombinant Vaccines), and by Region — Forecast till 2033
Report Code: EB_LS_450 | Page: 219
Vaccine Market Overview
The Vaccine Market Size is expected to reach USD 126.72 Billion by 2033. The Vaccine Market industry size accounted for USD 54.65 Billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 10.32% from 2023 to 2033. The vaccine market refers to the global industry involved in the research, development, production, distribution, and sale of vaccines. Vaccines are biological preparations that provide immunity to specific diseases by stimulating the body’s immune system to recognize and combat pathogens. The vaccine market includes a wide range of products aimed at preventing various infectious diseases in humans and animals.
The vaccine market is influenced by factors such as disease outbreaks, government immunization programs, advancements in biotechnology, and public awareness about the importance of vaccination. Economic and political factors, as well as supply chain logistics, also play significant roles in shaping the vaccine market.
Global Vaccine Market Synopsis
COVID-19 Impact Analysis
The COVID-19 pandemic had a profound impact on the vaccine market. The urgency of the pandemic led to unprecedented speed in vaccine development, with several COVID-19 vaccines being developed, tested, and approved within a year. The pandemic accelerated the adoption and success of mRNA vaccine technology, with Pfizer-BioNTech and Moderna’s mRNA vaccines leading the way. The demand for COVID-19 vaccines placed immense pressure on global supply chains, leading to shortages of raw materials and production bottlenecks. The need for ultra-cold storage for mRNA vaccines posed additional logistical challenges. The pandemic heightened public awareness about the importance of vaccines, leading to increased acceptance and demand. The vaccine market saw significant revenue growth due to the high demand for COVID-19 vaccines, benefiting pharmaceutical companies involved in their production.
Vaccine Market Dynamics
The major factors that have impacted the growth of Vaccine Market are as follows:
Drivers:
Ø Technological Advancements
Advances in biotechnology, such as mRNA technology, viral vector platforms, and recombinant DNA technology, accelerate vaccine development. Enhancements in manufacturing processes increase production efficiency and vaccine availability. The emergence of new diseases and outbreaks of existing ones drive demand for new vaccines. Large-scale health crises like the COVID-19 pandemic significantly boost vaccine development and distribution efforts. Increased public awareness about the benefits of vaccination drives higher vaccine uptake. Campaigns by health organizations and advocacy groups promote vaccine acceptance and compliance.
Restraint:
- Perception of High R&D Costs
The research and development of vaccines involve significant financial investments, including costs for clinical trials, which can be a barrier for many companies. The lengthy process from initial research to market approval can delay the availability of new vaccines. Misconceptions and fears about vaccine safety can lead to vaccine hesitancy, reducing vaccination rates. The spread of misinformation, particularly through social media, can undermine public confidence in vaccines. The lower profitability of vaccines compared to other pharmaceutical products can reduce the incentive for companies to invest in vaccine development. Unpredictable demand for vaccines, influenced by disease outbreaks and public health policies, can create market uncertainties.
Opportunity:
⮚     Expansion into Emerging Markets
Increasing healthcare infrastructure and rising awareness in emerging markets can drive demand for vaccines. Supportive policies and immunization programs in developing countries offer significant market opportunities. Strengthened focus on pandemic preparedness and response capabilities can boost investments in vaccine R&D and infrastructure. International efforts to enhance global health security can drive demand for a broader range of vaccines. Utilization of big data analytics and artificial intelligence can improve vaccine development, trial design, and epidemiological forecasting. Digital platforms for vaccine monitoring, distribution, and public education can enhance vaccine uptake and compliance.
Vaccine Market Segment Overview
By Type
Based on Type, the market is segmented based on Monovalent Vaccines and Multivalent Vaccines. The Monovalent Vaccines segment dominant the market. Growing disease prevalence has prompted immunization campaigns against specific infectious disease such as covid 19. The Raising prevalence of emerging and re-emerging infection disease, combined with R&D initiative, will propel the market for monovalent vaccine.
By Indication
Based on Indication, the market segment has been divided into the Pneumococcal Diseases, DTP, HPV, Influenza, Meningococcal Disease, Polio, Hepatitis, Rotavirus, MMR, Varicella, Herpes Zoster, Ebola, COVID and Others. The HPV segment dominant the market. There is a high demand for HPV vaccines among the population due to rising cases, as these vaccines protect against genital warts and most cases of cervical cancer. Also, HPV vaccines are highly approved by the US Food and Drug Administration (USFDA).
By Application
Based on Application, the market segment has been divided into the Conjugate Vaccines, Inactivated & Subunit, Live Attenuated and Recombinant Vaccines. The Live Attenuated segment dominant the market. Live attenuated vaccines are very effective vaccines used in the prevention of a variety of diseases, including influenza, chickenpox, measles, polio, and tuberculosis. Live-attenuated influenza vaccine (LAIV) proves advantageous in combating the infection among the population.
Global Vaccine Market Regional Analysis
Based on region, the global Vaccine Market has been divided into North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. North America is projected to dominate the use of the Vaccine Market followed by the Asia-Pacific and Europe regions.
Vaccine North America Market
North America holds a dominant position in the Vaccine Market. The United States and Canada are major players in the global vaccine market, with strong R&D capabilities and presence of leading pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson. High immunization rates and strong government support for vaccination programs drive the market. North America is a center for vaccine innovation, particularly in new technologies such as mRNA and recombinant vaccines. High costs and vaccine hesitancy in certain populations can be barriers.
Vaccine Asia-Pacific Market
The Asia-Pacific region has indeed emerged as the fastest-growing market for the Vaccine Market industry. Rapidly growing markets in China, India, Japan, and South Korea show significant potential due to increasing healthcare spending and government support. Countries like India and China are major vaccine producers, supplying both domestic and international markets. Efforts to expand vaccine access in rural and underserved areas present opportunities for market growth.
Competitive Landscape
The global Vaccine Market is highly competitive, with numerous players offering a wide range of software solutions. The competitive landscape is characterized by the presence of established companies, as well as emerging startups and niche players. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as product launches, and strategic alliances.
Prominent Players:
- BAVARIAN NORDIC
- SINOVAC BIOTECH LTD.
- PANACEA BIOTEC
- DYNAVAX TECHNOLOGIES CORPORATION
- BHARAT BIOTECH
- ASTELLAS PHARMA INC
- MERCK & CO. INC.
- SANOFI PASTEUR
- ASTRAZENECA
- SERUM INSTITUTE OF INDIA PVT. LTD.
- VALNEVA
Scope of the Report
Global Vaccine Market, by Type
- Monovalent Vaccines
- Multivalent Vaccines
Global Vaccine Market, by Indication
- Pneumococcal Diseases
- DTP
- HPV
- Influenza
- Meningococcal Disease
- Polio
- Hepatitis
- Rotavirus
- MMR
- Varicella
- Herpes Zoster
- Ebola
- COVID
- Others
Global Vaccine Market, by Application
- Conjugate Vaccines
- Inactivated & Subunit
- Live Attenuated
- Recombinant Vaccines
Global Vaccine Market, by Region
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Benelux
- Nordic
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Indonesia
- Austalia
- Malaysia
- India
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of Middle East & Africa
| Parameters | Indicators |
|---|---|
| Market Size | 2033: $126.72 Billion/strong> |
| CAGR | 10.32% CAGR (2023-2033) |
| Base year | 2022 |
| Forecast Period | 2023-2033 |
| Historical Data | 2021 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Key Segmentations | Type, Indication, Application |
| Geographies Covered | North America, Europe, Asia-Pacific, Latin America, Middle East, Africa |
| Key Vendors | BAVARIAN NORDIC, SINOVAC BIOTECH LTD., PANACEA BIOTEC, DYNAVAX TECHNOLOGIES CORPORATION, BHARAT BIOTECH, ASTELLAS PHARMA INC, MERCK & CO. INC., SANOFI PASTEUR, ASTRAZENECA, SERUM INSTITUTE OF INDIA PVT. LTD. And VALNEVA |
| Key Market Opportunities | • Expansion into Emerging Markets • Digital and Data Technologies |
| Key Market Drivers | • Technological Advancements • Disease Prevalence and Outbreaks |
REPORT CONTENT BRIEF:
- High-level analysis of the current and future Vaccine Market trends and opportunities
- Detailed analysis of current market drivers, restraining factors, and opportunities in the future
- Vaccine Market historical market size for the year 2021, and forecast from 2023 to 2033
- Vaccine Market share analysis at each product level
- Competitor analysis with detailed insight into its product segment, Government & Defense strength, and strategies adopted.
- Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
- To identify and understand the various factors involved in the global Vaccine Market affected by the pandemic
- To provide a detailed insight into the major companies operating in the market. The profiling will include the Government & Defense health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.
Press Release
Global Pharmaceutical Manufacturing Market to Reach $1.38 Trillion by 2035 with 7.35% CAGR, New Research Shows
The Global Mammography Market Is Estimated To Record a CAGR of Around 10.29% During The Forecast Period
Glue Stick Market to Reach USD 2.35 Billion by 2034
Podiatry Service Market to Reach USD 11.88 Billion by 2034
Microfluidics Technology Market to Reach USD 32.58 Billion by 2034
Ferric Chloride Market to Reach USD 10.65 Billion by 2034
Family Practice EMR Software Market to Reach USD 21.52 Billion by 2034
Electric Hairbrush Market to Reach USD 15.95 Billion by 2034
Daily Bamboo Products Market to Reach USD 143.52 Billion by 2034
Cross-border E-commerce Logistics Market to Reach USD 112.65 Billion by 2034
Frequently Asked Questions (FAQ)
2.What is the growth rate of the global Vaccine Market?
- The global Vaccine Market is growing at a CAGR of 10.32% over the next 10 years
3.Which region has the highest growth rate in the market of Vaccine Market?
- Asia Pacific is expected to register the highest CAGR during 2023-2033
4.Which region has the largest share of the global Vaccine Market?
- North America holds the largest share in 2022
5.Who are the key players in the global Vaccine Market?
BAVARIAN NORDIC, SINOVAC BIOTECH LTD., PANACEA BIOTEC, DYNAVAX TECHNOLOGIES CORPORATION, BHARAT BIOTECH, ASTELLAS PHARMA INC, MERCK & CO. INC., SANOFI PASTEUR, ASTRAZENECA, SERUM INSTITUTE OF INDIA PVT. LTD. And VALNEVA. are the major companies operating in the market
6.Do you offer Post Sale Support?
- Yes, we offer 16 hours of analyst support to solve the queries
7.Do you sell particular sections of a report?
Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives
Table of Content
CHAPTER 1.________________________________________________________________________________________ Executive Summary CHAPTER 2._________________________________________________________________________________________ Scope of the Study 2.1. Market Definition 2.2. Market Scope & Segmentation 2.2.1. Objective of Report CHAPTER 3.____________________________________________________________________________________ Evolve BI Methodology 3.1. Data Collection & Validation Approach 3.2. Market Size Estimation and Forecast CHAPTER 4._________________________________________________________________________________________ Exclusive Analysis 4.1. Market Opportunity Score 4.1.1. Type Segement – Market Opportunity Score 4.1.2. Indication Segment – Market Opportunity Score 4.1.3. Application Segment – Market Opportunity Score 4.2. Key Market Influencing Indicators CHAPTER 5._______________________________________________________________________________ Market Insights and Trends 5.1. Value Chain Analysis 5.1.1. Raw Material 5.1.2. Manufacturing Process 5.1.3. Distribution Channel 5.1.4. End User 5.2. Porter’s Five Forces Analysis 5.2.1. Bargaining Power of Buyers 5.2.2. Bargaining Power of Suppliers 5.2.3. Threat of New Entrant 5.2.4. Threat of Substitute 5.2.5. Industry Rivalry 5.3. COVID-19 Impact and Post COVID Scenario on Industrial Air Filtration Market 5.3.1. Impact of COVID-19 5.3.2. Government Support and Industry Revival Policies 5.3.3. Measures Taken by Companies to Mitigate Negative Impact 5.3.4. Post COVID Trend CHAPTER 6.__________________________________________________________________________________________ MArket Dynamics 6.1. Introduction 6.2. Drivers 6.2.1. Driver 1 6.2.2. Driver 2 6.2.3. Driver 3 6.3. Restraints 6.3.1. Restraint 1 6.3.2. Restraint 2 6.4. Opportunity 6.4.1. Opportunity 1 CHAPTER 7.________________________________________________________________ Industrial Air Filtration Market, By Type 7.1. Introduction 7.1.1. Monovalent Vaccines 7.1.2. Multivalent Vaccines CHAPTER 8. Industrial Air Filtration Market, By Indication 8.1. Introduction 8.1.1. Pneumococcal Diseases 8.1.2. DTP 8.1.3 HPV 8.1.4 Influenza 8.1.5 Meningococcal Disease 8.1.6 Polio 8.1.7 Hepatitis 8.1.8 Rotavirus 8.1.9 MMR 8.1.10 Varicella 8.1.11 Herpes Zoster 8.1.12 Ebola 8.1.13 COVID 8.1.14 Others CHAPTER 9. Industrial Air Filtration Market, By Application 9.1. Introduction 9.1.1. Conjugate Vaccines 9.1.2 Inactivated & Subunit 9.1.3 Live Attenuated 9.1.4 Recombinant Vaccines CHAPTER 10. Industrial Air Filtration Market, By Region 10.1. Introduction 10.2. NORTH AMERICA 10.2.1. North America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million) 10.2.2. North America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.2.3. North America: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.2.4. North America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.2.5. US 10.2.5.1.___________________________________________ US: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.2.5.2._____________________________________ US: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.2.5.3.___________________________________ US: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.2.6. CANADA 10.2.6.1._____________________________________ Canada: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.2.6.2.________________________________ Canada: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.2.6.3.______________________________ Canada: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.2.7. MEXICO 10.2.7.1.______________________________________ Mexico: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.2.7.2.________________________________ Mexico: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.2.7.3.______________________________ Mexico: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3. Europe 10.3.1. Europe: Market Size and Forecast, By Country, 2023 – 2033 ($ Million) 10.3.2. Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.3. Europe: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.4. Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.5. U.K. 10.3.5.1._________________________________________ U.K.: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.5.2.___________________________________ U.K.: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.5.3.__________________________________ U.K.: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.6. GERMANY 10.3.6.1.___________________________________ Germany: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.6.2.______________________________ Germany: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.6.3.____________________________ Germany: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.7. FRANCE 10.3.7.1.______________________________________ France: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.7.2.________________________________ France: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.7.3._______________________________ France: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.8. ITALY 10.3.8.1._________________________________________ Italy: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.8.2.___________________________________ Italy: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.8.3._________________________________ Italy: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.9. SPAIN 10.3.9.1.________________________________________ Spain: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.9.2.__________________________________ Spain: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.9.3.________________________________ Spain: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.10.________________________________________________________________________________________________________ BENELUX 10.3.10.1.__________________________________ BeNeLux: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.10.2.____________________________ BeNeLux: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.10.3.___________________________ BeNeLux: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.11.___________________________________________________________________________________________________________ RUSSIA 10.3.11.1._____________________________________ Russia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.11.2._______________________________ Russia: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.11.3.______________________________ Russia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.3.12._______________________________________________________________________________________________ REST OF EUROPE 10.3.12.1.____________________________ Rest of Europe: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.3.12.2.______________________ Rest of Europe: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.3.12.3.____________________ Rest of Europe: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4. Asia Pacific 10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2023 – 2033 ($ Million) 10.4.2. Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.3. Asia Pacific: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.4. Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.5. CHINA 10.4.5.1._______________________________________ China: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.5.2._________________________________ China: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.5.3.________________________________ China: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.6. JAPAN 10.4.6.1._______________________________________ Japan: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.6.2.__________________________________ Japan: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.6.3.________________________________ Japan: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.7. INDIA 10.4.7.1.________________________________________ India: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.7.2.__________________________________ India: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.7.3._________________________________ India: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.8. SOUTH KOREA 10.4.8.1.________________________________ South Korea: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.8.2.__________________________ South Korea: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.8.3.________________________ South Korea: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.9. THAILAND 10.4.9.1.____________________________________ Thailand: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.9.2.______________________________ Thailand: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.9.3.____________________________ Thailand: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.10.______________________________________________________________________________________________________ INDONESIA 10.4.10.1._________________________________ Indonesia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.10.2.___________________________ Indonesia: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.10.3.__________________________ Indonesia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.11._______________________________________________________________________________________________________ MALAYSIA 10.4.11.1.__________________________________ Malaysia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.11.2._____________________________ Malaysia: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.11.3.___________________________ Malaysia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.12.______________________________________________________________________________________________________ AUSTRALIA 10.4.12.1.__________________________________ Australia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.12.2.____________________________ Australia: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.12.3.___________________________ Australia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.4.13.__________________________________________________________________________________________ REST FO ASIA PACIFIC 10.4.13.1._______________________ Rest fo Asia Pacific: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.4.13.2._________________ Rest fo Asia Pacific: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.4.13.3.________________ Rest fo Asia Pacific: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.5. South America 10.5.1. South America: Market Size and Forecast, By Country, 2023 – 2033 ($ Million) 10.5.2. South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.5.3. South America: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.5.4. South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.5.5. BRAZIL 10.5.5.1._______________________________________ Brazil: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.5.5.2._________________________________ Brazil: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.5.5.3.________________________________ Brazil: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.5.6. ARGENTINA 10.5.6.1.___________________________________ Argentina: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.5.6.2._____________________________ Argentina: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.5.6.3.___________________________ Argentina: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.5.7. REST OF SOUTH AMERICA 10.5.7.1._____________________ Rest of South America: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.5.7.2._______________ Rest of South America: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.5.7.3._____________ Rest of South America: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6. Middle East & Africa 10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2023 – 2033 ($ Million) 10.6.2. Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.3. Middle East & Africa: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6.5. SAUDI ARABIA 10.6.5.1._______________________________ Saudi Arabia: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.5.2._________________________ Saudi Arabia: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.5.3.________________________ Saudi Arabia: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6.6. UAE 10.6.6.1._________________________________________ UAE: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.6.2.___________________________________ UAE: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.6.3.__________________________________ UAE: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6.7. EGYPT 10.6.7.1._______________________________________ Egypt: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.7.2._________________________________ Egypt: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.7.3.________________________________ Egypt: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6.8. SOUTH AFRICA 10.6.8.1.________________________________ South Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.8.2.__________________________ South Africa: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.8.3.________________________ South Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) 10.6.9. REST OF MIDDLE EAST & AFRICA 10.6.9.1.______________ Rest of Middle East & Africa: Market Size and Forecast, By Type, 2023 – 2033 ($ Million) 10.6.9.2.________ Rest of Middle East & Africa: Market Size and Forecast, By Indication, 2023 – 2033 ($ Million) 10.6.9.3._______ Rest of Middle East & Africa: Market Size and Forecast, By Application, 2023 – 2033 ($ Million) CHAPTER 12.___________________________________________________________________________________ Competitive Landscape 12.1. Competitior Benchmarking 2023 12.2. Market Share Analysis 12.3. Key Developments Analysis By Top 5 Companies 12.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players CHAPTER 13._________________________________________________________________________________________ Company Profiles 13.1. BAVARIAN NORDIC 13.1.1. Hanon Systems 13.1.2. Financial Analysis 13.1.2.1.___________________________________________________ Business Segment Revenue, 2020, 2021, 2022, $ Million 13.1.2.2.____________________________________________________________________ Geographic Revenue Mix, 2022 (% Share) 13.1.3. Product Portfolio 13.1.4. Recent Development and Strategies Adopted 13.1.5. SWOT Analysis 13.2. SINOVAC BIOTECH LTD 13.3. PANACEA BIOTEC 13.4. DYNAVAX TECHNOLOGIES CORPORATION 13.5. BHARAT BIOTECH 13.6. ASTELLAS PHARMA INC 13.7. MERCK & CO. INC 13.8. SANOFI PASTEUR 13.9. ASTRAZENECA 13.10. SERUM INSTITUTE OF INDIA PVT. LTD. 13.11. VALNEVA.
Connect to Analyst
Research Methodology
Our Most Viewed Report and gain instant expertise
